Use of metformin in the setting of mild-to-moderate renal insufficiency

doi:10.2337/dc10-2361

Review

. 2011 Jun;34(6):1431-7.

doi: 10.2337/dc10-2361.

Use of metformin in the setting of mild-to-moderate renal insufficiency

Kasia J Lipska¹, Clifford J Bailey, Silvio E Inzucchi

Affiliations

PMID: 21617112
PMCID: PMC3114336
DOI: 10.2337/dc10-2361

Review

Use of metformin in the setting of mild-to-moderate renal insufficiency

Kasia J Lipska et al. Diabetes Care. 2011 Jun.

. 2011 Jun;34(6):1431-7.

doi: 10.2337/dc10-2361.

Authors

Kasia J Lipska¹, Clifford J Bailey, Silvio E Inzucchi

Affiliation

¹ Robert Wood Johnson Clinical Scholars Program, Yale University School of Medicine, New Haven, Connecticut, USA.

PMID: 21617112
PMCID: PMC3114336
DOI: 10.2337/dc10-2361

No abstract available

PubMed Disclaimer

Comment in

El uso de metformina en el contexto de insuficiencia renal leve o moderada.
Gómez-Huelgas R; Grupo de Diabetes y Obesidad de la Sociedad Española de Medicina Interna. Gómez-Huelgas R, et al. Rev Clin Esp. 2012 Feb;212(2):105. doi: 10.1016/j.rce.2011.09.005. Rev Clin Esp. 2012. PMID: 22413134 Spanish. No abstract available.

Cited by

Combination of linagliptin and metformin for the treatment of patients with type 2 diabetes.
Haak T. Haak T. Clin Med Insights Endocrinol Diabetes. 2015 Jan 4;8:1-6. doi: 10.4137/CMED.S10360. eCollection 2015. Clin Med Insights Endocrinol Diabetes. 2015. PMID: 25628514 Free PMC article. Review.
Management of post-transplant diabetes.
Therasse A, Wallia A, Molitch ME. Therasse A, et al. Curr Diab Rep. 2013 Feb;13(1):121-9. doi: 10.1007/s11892-012-0346-8. Curr Diab Rep. 2013. PMID: 23188594 Review.
Lactic Acidosis Associated with Metformin in Patients with Diabetic Kidney Disease.
Rahman F, Tuba S. Rahman F, et al. Med Arch. 2022 Aug;76(4):297-300. doi: 10.5455/medarh.2022.76.297-300. Med Arch. 2022. PMID: 36313954 Free PMC article. Review.
Role of Primary Care Clinicians in the Management of Patients With Type 2 Diabetes and Cardiorenal Diseases.
Kushner PR, Cavender MA, Mende CW. Kushner PR, et al. Clin Diabetes. 2022 Fall;40(4):401-412. doi: 10.2337/cd21-0119. Clin Diabetes. 2022. PMID: 36381309 Free PMC article.
[Metformin-induced lactic acidosis : Severe symptoms with difficult diagnostics].
Decker SO, Wortmann M, Siegler BH, Ulrich A, Hofer S, Brenner T. Decker SO, et al. Anaesthesist. 2015 Apr;64(4):292-7. doi: 10.1007/s00101-015-0017-7. Epub 2015 Apr 14. Anaesthesist. 2015. PMID: 25870002 German.

See all "Cited by" articles

References

1. Herrington WG, Levy JB. Metformin: effective and safe in renal disease? Int Urol Nephrol 2008;40:411–417 - PubMed
1. McCormack J, Johns K, Tildesley H. Metformin’s contraindications should be contraindicated. CMAJ 2005;173:502–504 - PMC - PubMed
1. Lalau JD. Lactic acidosis induced by metformin: incidence, management and prevention. Drug Saf 2010;33:727–740 - PubMed
1. Bailey CJ. Metformin: effects on micro and macrovascular complications in type 2 diabetes. Cardiovasc Drugs Ther 2008;22:215–224 - PubMed
1. Gerstein HC, Miller ME, Byington RP, et al. ; Action to Control Cardiovascular Risk in Diabetes Study Group Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545–2559 - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information

[1] Herrington WG, Levy JB. Metformin: effective and safe in renal disease? Int Urol Nephrol 2008;40:411–417 - PubMed

[2] Herrington WG, Levy JB. Metformin: effective and safe in renal disease? Int Urol Nephrol 2008;40:411–417 - PubMed

[3] McCormack J, Johns K, Tildesley H. Metformin’s contraindications should be contraindicated. CMAJ 2005;173:502–504 - PMC - PubMed

[4] McCormack J, Johns K, Tildesley H. Metformin’s contraindications should be contraindicated. CMAJ 2005;173:502–504 - PMC - PubMed

[5] Lalau JD. Lactic acidosis induced by metformin: incidence, management and prevention. Drug Saf 2010;33:727–740 - PubMed

[6] Lalau JD. Lactic acidosis induced by metformin: incidence, management and prevention. Drug Saf 2010;33:727–740 - PubMed

[7] Bailey CJ. Metformin: effects on micro and macrovascular complications in type 2 diabetes. Cardiovasc Drugs Ther 2008;22:215–224 - PubMed

[8] Bailey CJ. Metformin: effects on micro and macrovascular complications in type 2 diabetes. Cardiovasc Drugs Ther 2008;22:215–224 - PubMed

[9] Gerstein HC, Miller ME, Byington RP, et al. ; Action to Control Cardiovascular Risk in Diabetes Study Group Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545–2559 - PMC - PubMed

[10] Gerstein HC, Miller ME, Byington RP, et al. ; Action to Control Cardiovascular Risk in Diabetes Study Group Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545–2559 - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Use of metformin in the setting of mild-to-moderate renal insufficiency

Affiliation

Use of metformin in the setting of mild-to-moderate renal insufficiency

Authors

Affiliation

Comment in

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Comment in

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical